Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Goodall

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
Cancer Cell|November 22, 2024
Elucidating acquired PARP inhibitor resistance in advanced prostate cancerGeorge Seed, Nick Beije, Wei Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by ApheresisMaryou B Lambros, George Seed, Semini Sumanasuriya, et al.
Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Gastroenterology|April 30, 2013
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studiesDavid Ellinghaus, Hu Zhang, Sebastian Zeissig, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
Cancer Cell|November 22, 2024
Elucidating acquired PARP inhibitor resistance in advanced prostate cancerGeorge Seed, Nick Beije, Wei Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by ApheresisMaryou B Lambros, George Seed, Semini Sumanasuriya, et al.
Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Gastroenterology|April 30, 2013
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studiesDavid Ellinghaus, Hu Zhang, Sebastian Zeissig, et al.
Pageof 6